基本信息
-
人胰高血糖素样肽-1
-
106612-94-6
-
7-37-Glucagon-like peptide I (human); Insulinotropin (human); Peptide GLP-1 (human glucose-lowering peptide-1)
-
C151H228N40O47
-
3355.67
-
7-37-Glucagon-likepeptide I (human)
-
-
1.48±0.1 g/cm3(Predicted)
-
Glucagon-relatedpeptide 1 (Rana catesbeiana), 3-L-glutamicacid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-31-glycine-32-de-L-lysine-;10: PN: US20080299096 SEQID: 9 unclaimed sequence; 10: PN: WO03103572 SEQID: 16unclaimed protein; 10: PN: WO2008150821 SEQID: 9 unclaimed protein; 111: PN:WO0198331 TABLE: 1 claimed protein; 116: PN: WO2007124463 SEQID: 1 claimedsequence; 11: PN: EP1972349 SEQID: 1 unclaimed sequence; 11: PN: US6284725SEQID: 3 unclaimed protein; 11: PN: WO0066138 PAGE: 11 unclaimed protein; 11:PN: WO0136643 FIGURE: 4 unclaimed protein; 11: PN: WO2008101017 SEQID: 50unclaimed sequence; 137: PN: WO2006074600 SEQID: 2 unclaimed sequence; 13: PN:WO2004056313 SEQID: 11 unclaimed sequence; 14: PN: WO2005097175 SEQID: 15claimed protein; 15: PN: WO2007076319 SEQID: 15 claimed protein; 15: PN:WO2007081302 SEQID: 15 claimed sequence; 17: PN: WO0039278 SEQID: 23 unclaimedprotein; 18: PN: WO2004022004 SEQID: 2 claimed sequence; 18: PN: WO2007062531SEQID: 18 unclaimed sequence; 19: PN: WO02072605 SEQID: 19 unclaimed protein;1: PN: CN101463081 SEQID: 1 claimed protein; 1: PN: CN1982336 SEQID: 1unclaimed sequence; 1: PN: US20040143104 SEQID: 21 unclaimed sequence; 1: PN:US20060286129 SEQID: 1 claimed sequence; 1: PN: WO0155213 SEQID: 1 claimedprotein; 1: PN: WO03014318 SEQID: 21 claimed protein; 1: PN: WO2004093823SEQID: 1 claimed protein; 1: PN: WO2005019262 SEQID: 1 claimed protein; 1: PN:WO2005027978 SEQID: 1 unclaimed protein; 1: PN: WO2005028516 SEQID: 1 claimedprotein; 1: PN: WO2006126673 SEQID: 1 claimed protein; 1: PN: WO2007049695SEQID: 2 claimed sequence; 1: PN: WO2008097504 PAGE: 42 unclaimed sequence; 1:PN: WO2008132477 PAGE: 5 unclaimed sequence; 1: PN: WO2009020802 SEQID: 3unclaimed sequence; 1: PN: WO2009035540 SEQID: 3 unclaimed sequence; 1: PN:WO2009067268 PAGE: 9 unclaimed sequence; 1: PN: WO2009080032 SEQID: 1 unclaimedsequence; 1: PN: WO2009083549 SEQID: 1 unclaimed sequence;
-
-
-
-
详细信息
杰肽生物科技有限公司提供专业的脊髓胰高血糖素样肽-1(GLP-1)服务,制备纯化严格按照国外生产标准,质量完美,纯度可以达到98%以上。交货期短,量大还有优惠。以下是一部分GLP-1肽的序列,如果您需要合成其序列的GLP-1肽,欢迎您随时与我们这边联系。
GLP-1(7-37)(Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)-RIA Kit
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
GLP-1(7-36)-Amide(Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)-EIA Kit
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
GLP-1(Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)
His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
GLP-1(2-24)[Cys0](Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)
Cys-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala
GLP-1(28-36)-Amide(Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)
Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
GLP-1(12-24)[Cys0]
Cys-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala
GLP-1(9-36)-Amide(Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)
Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
GLP-1(32-36)-Amide(Human,Rat,Mouse,Porcine,Bovine,Canine,Ovine)
Leu-Val-Lys-Gly-Arg-NH2
联系人:何武正
联系电话:021-50835580;15000382494
QQ:2543947147
邮箱:wuzheng@synpeptide.com
公司简介
上海杰肽生物科技有限公司是中华人民共和国高新技术产业,公司成立于2013年。由美国总部Abta博士ALisa博士以及国内一大批教授领衔的杰肽生物是一家致力于多肽类试剂和抗体服务的集研究,开发和生产于一体的高新技术企业。作为国内较早从事多肽研究开发的生产企业,通过多年努力,杰肽不仅仅在产品的质量安全,并且在技术服务和品牌建设上都走在行业前列。
杰肽生物拥有世界的多肽合成设备,并制定了先进的管理制度和科学的生产流程,能同时合成上千条不同序列的多肽,可以极大地降低多肽合成的综合成本,从而为全球的科研用户提供高性价比的产品和服务,为客户赢得了宝贵的科研时间 ,降低了科研费用。
公司坚持"大型品牌、高端质量、专业服务"的发展战略,秉承"质量,服务至上"的经营理念,拥有专业的研发团队,先进的仪器设备,领先的技术水平,致力为科研工作者及大型药企提供优质的多肽以及相关产品。 严谨的管理、超卓的设备,着力打造具有核心竞争力的企业。